Search research articles
Contact Us
Filters
Showing results (251-260 of 504) with videos related to
Page
of 51
Sort By:
Frontiers in Oncology
|
April 25, 2022
Targeting ALK Rearrangements in NSCLC: Current State of the Art
Ling Peng, Liping Zhu, Yilan Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 9, 2009
The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals
Naa Torshie Annan, Mark Nelson, Sundhiya Mandalia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study
Rachael Jones, Justin Stebbing, Mark Nelson, et al.
The Journal of Antimicrobial Chemotherapy
|
February 6, 2004
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)
Justin Stebbing, Mark Nelson, Chloe Orkin, et al.
Journal of Clinical Pathology
|
May 5, 2012
Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy
Daniel G Ezra, Jonathan Krell, Geoffrey E Rose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective study
Justin Stebbing, Laura Waters, Liz Davies, et al.
Expert Review of Molecular Diagnostics
|
October 30, 2016
Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancer
Mireia Mato Prado, Adam E Frampton, Elisa Giovannetti, et al.
American Journal of Hematology
|
February 9, 2008
HIV-associated multicentric Castleman's disease
Justin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
Archives of Internal Medicine
|
September 24, 2008
Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes
Rachael Jones, Mark Nelson, Mark Bower, et al.
Expert Review of Anticancer Therapy
|
November 26, 2011
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma
Adam E Frampton, Jonathan Krell, Jimmy Jacob, et al.
Page
of 51
Search research articles
Search
Showing results (251-260 of 504) with videos related to
Sort By:
Page
of 51
Frontiers in Oncology
|
April 25, 2022
Targeting ALK Rearrangements in NSCLC: Current State of the Art
Ling Peng, Liping Zhu, Yilan Sun, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 9, 2009
The nucleoside backbone affects durability of efavirenz- or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals
Naa Torshie Annan, Mark Nelson, Sundhiya Mandalia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 17, 2004
Renal dysfunction with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy regimens is not observed more frequently: a cohort and case-control study
Rachael Jones, Justin Stebbing, Mark Nelson, et al.
The Journal of Antimicrobial Chemotherapy
|
February 6, 2004
A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART)
Justin Stebbing, Mark Nelson, Chloe Orkin, et al.
Journal of Clinical Pathology
|
May 5, 2012
Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy
Daniel G Ezra, Jonathan Krell, Geoffrey E Rose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2005
Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective study
Justin Stebbing, Laura Waters, Liz Davies, et al.
Expert Review of Molecular Diagnostics
|
October 30, 2016
Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancer
Mireia Mato Prado, Adam E Frampton, Elisa Giovannetti, et al.
American Journal of Hematology
|
February 9, 2008
HIV-associated multicentric Castleman's disease
Justin Stebbing, Liron Pantanowitz, Farshid Dayyani, et al.
Archives of Internal Medicine
|
September 24, 2008
Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes
Rachael Jones, Mark Nelson, Mark Bower, et al.
Expert Review of Anticancer Therapy
|
November 26, 2011
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma
Adam E Frampton, Jonathan Krell, Jimmy Jacob, et al.
Page
of 51